Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Animalcare ( (GB:ANCR) ) is now available.
Animalcare Group plc reported strong financial performance for the year ended December 2024, with revenues from continuing operations increasing by 4.9% to £74.2m. The company completed a transformational acquisition of Randlab, enhancing its position in the equine sector and expanding its reach into the Asia Pacific markets. The acquisition, along with the sale of non-core assets, strengthened the balance sheet and supported both organic and inorganic growth strategies. The Group’s strategic focus on R&D and product development, particularly in the novel VHH antibody program, positions it well for future growth. The company’s robust financial health and strategic acquisitions underscore its commitment to long-term growth and market expansion.
More about Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organization. It operates in seven European countries, as well as Australia and New Zealand, and exports to approximately 40 countries globally. The Group focuses on bringing new and innovative products to market through its development pipeline, partnerships, and acquisitions.
YTD Price Performance: -2.46%
Average Trading Volume: 49,238
Technical Sentiment Signal: Sell
Current Market Cap: £164.2M
For detailed information about ANCR stock, go to TipRanks’ Stock Analysis page.